These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 14573791

  • 1. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
    Mann KK, Rephaeli A, Colosimo AL, Diaz Z, Nudelman A, Levovich I, Jing Y, Waxman S, Miller WH.
    Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
    [Abstract] [Full Text] [Related]

  • 2. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR, He RY.
    Cancer Res; 1990 Oct 01; 50(19):6268-73. PubMed ID: 2400989
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
    Zheng X, Chang RL, Cui XX, Kelly KA, Shih WJ, Lin Y, Strair R, Suh J, Han ZT, Rabson A, Conney AH.
    Oncol Res; 2000 Oct 01; 12(9-10):419-27. PubMed ID: 11697820
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
    Taimi M, Chen ZX, Breitman TR.
    Oncol Res; 1998 Oct 01; 10(2):75-84. PubMed ID: 9666515
    [Abstract] [Full Text] [Related]

  • 5. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U.
    Cancer Res; 1993 Dec 15; 53(24):6036-41. PubMed ID: 8261419
    [Abstract] [Full Text] [Related]

  • 6. Response of retinoic acid-resistant KG1 cells to combination of retinoic acid with diverse histone deacetylase inhibitors.
    Savickiene J, Treigyte G, Magnusson KE, Navakauskiene R.
    Ann N Y Acad Sci; 2009 Aug 15; 1171():321-33. PubMed ID: 19723072
    [Abstract] [Full Text] [Related]

  • 7. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity.
    Nudelman A, Rephaeli A.
    J Med Chem; 2000 Jul 27; 43(15):2962-6. PubMed ID: 10956204
    [Abstract] [Full Text] [Related]

  • 8. Growth, differentiation, and death of retinoic acid-treated human acute promyelocytic leukemia NB4 cells.
    Taimi M, Breitman TR.
    Exp Cell Res; 1997 Jan 10; 230(1):69-75. PubMed ID: 9013708
    [Abstract] [Full Text] [Related]

  • 9. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
    Taimi M, Breitman TR.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):432-6. PubMed ID: 9125196
    [Abstract] [Full Text] [Related]

  • 10. Potential applications of cytodifferentiation therapy in hematologic malignancies.
    Breitman TR, Chen ZX, Takahashi N.
    Semin Hematol; 1994 Oct 17; 31(4 Suppl 5):18-25. PubMed ID: 7831581
    [Abstract] [Full Text] [Related]

  • 11. In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group.
    Um SJ, Han HS, Kwon YJ, Park SH, Bae TS, Rho YS, Sin HS.
    Oncol Rep; 2004 Mar 17; 11(3):719-26. PubMed ID: 14767528
    [Abstract] [Full Text] [Related]

  • 12. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
    Coradini D, Pellizzaro C, Scarlata I, Zorzet S, Garrovo C, Abolafio G, Speranza A, Fedeli M, Cantoni S, Sava G, Daidone MG, Perbellini A.
    Leukemia; 2006 May 17; 20(5):785-92. PubMed ID: 16525489
    [Abstract] [Full Text] [Related]

  • 13. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ, Baselga J, Reuter VE, Mellado B, Myers ML, Bosl GJ, Spinella MJ, Dmitrovsky E.
    Oncogene; 1998 Aug 13; 17(6):761-7. PubMed ID: 9715278
    [Abstract] [Full Text] [Related]

  • 14. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
    Bastie JN, Balitrand N, Guillemot I, Chomienne C, Delva L.
    Exp Cell Res; 2005 Nov 01; 310(2):319-30. PubMed ID: 16181625
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells.
    Tanaka T, Satoh T, Onozawa Y, Kohroki J, Itoh N, Ishidate M, Muto N, Tanaka K.
    Cell Biol Int; 1999 Nov 01; 23(8):541-50. PubMed ID: 10704238
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome.
    Gao Y, Camacho LH, Mehta K.
    Leuk Res; 2007 Apr 01; 31(4):455-63. PubMed ID: 16920192
    [Abstract] [Full Text] [Related]

  • 17. 4-Oxoretinol, a metabolite of retinol in the human promyelocytic leukemia cell line NB4, induces cell growth arrest and granulocytic differentiation.
    Faria TN, Rivi R, Derguini F, Pandolfi PP, Gudas LJ.
    Cancer Res; 1998 May 01; 58(9):2007-13. PubMed ID: 9581846
    [Abstract] [Full Text] [Related]

  • 18. Targeting PKC delta-mediated topoisomerase II beta overexpression subverts the differentiation block in a retinoic acid-resistant APL cell line.
    McNamara S, Nichol JN, Wang H, Miller WH.
    Leukemia; 2010 Apr 01; 24(4):729-39. PubMed ID: 20200558
    [Abstract] [Full Text] [Related]

  • 19. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM.
    Leuk Res; 2009 Jul 01; 33(7):958-63. PubMed ID: 19013639
    [Abstract] [Full Text] [Related]

  • 20. Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia.
    Zheng PZ, Wang KK, Zhang QY, Huang QH, Du YZ, Zhang QH, Xiao DK, Shen SH, Imbeaud S, Eveno E, Zhao CJ, Chen YL, Fan HY, Waxman S, Auffray C, Jin G, Chen SJ, Chen Z, Zhang J.
    Proc Natl Acad Sci U S A; 2005 May 24; 102(21):7653-8. PubMed ID: 15894607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.